- Lebanon's Hezbollah in disarray after second wave of deadly blasts
- Equity markets, yen rally after jumbo US rate cut
- Meta and Spotify blast EU decisions on AI
- Hasan takes three as Bangladesh rattle India in first Test
- Two killed during police operation in New Caledonia
- Flood-hit region leaders to meet in Poland to discuss EU aid
- Sri Lanka to vote in first poll since economic collapse
- Hong Kong probe finds Cathay Airbus defect could cause 'extensive' damage
- AI development cannot be left to market whim, UN experts warn
- All Blacks primed for 'hell' of a Wallabies clash
- Japan firm says no longer makes radio reportedly used in Lebanon blasts
- Zoom fatigue? Try some nature in your background: study
- Boeing to start large-scale furloughs with Seattle strike talks stalled
- Japan walkie-talkie maker says investigating after Lebanon blasts
- Slipper to become most-capped Wallaby in All Blacks clash
- Tokyo surges on weak yen as Asian traders cheer big US rate cut
- Vast France building project sunk by sea level rise fears
- UK campaigners in green energy standoff reject 'nimby' label
- Rainbow warriors: Three things to watch at cycling world championships
- Lebanon's Hezbollah in disarray after second wave of device blasts
- China's 'full-time dads' challenge patriarchal norms
- What we know about the fire 'pandemic' plaguing Brazil
- X says Brazil service restoration 'inadvertent' and 'temporary'
- Amazon drought leaves Colombian border town high and dry
- Some Cubans depend on sugar water as food shortages bite
- Saudi crown prince says no Israel ties without Palestinian state
- Canada to further cut international student, foreign worker permits
- YouTube launches new TV-focused tools for creators
- White Sox heading for worst season in MLB history
- China the top challenge in US history: senior diplomat
- Hong Kong democracy tycoon's son warns time running out
- New migraine drugs no better than cheap painkillers: big study
- Sean 'Diddy' Combs again denied bail in sex trafficking case
- Brewers clinch division title as MLB playoff race heats up
- Man City blunted by 'giant' Inter in Champions League stalemate
- US stocks dip despite larger Fed interest rate cut
- Man City held by Inter as PSG pinch win in Champions League
- All Blacks recall Beauden Barrett for Australia Test
- Fears of all-out war as new Lebanon device blasts kill 20, wound 450
- Spurs late show saves Postecoglou blushes at Coventry
- PSG snatch late goal to beat Champions League debutants Girona
- Gittens' late double gives Dortmund Champions League win at Brugge
- Man City blunted by Inter in Champions League stalemate
- Hidden talent: French Olympic star Marchand opts for disguise
- MrBeast named in California lawsuit over 'Beast Games' show
- Gauff splits with Gilbert as coach after 14-month run
- Hundreds of thousands at risk in Sudan's El-Fasher: UN
- Harvey Weinstein pleads not guilty to new sex crime charge
- Venezuelan opposition candidate says letter conceding election was coerced
- Ukraine official claims Russian advance in Kursk has been 'stopped'
From new treatments to AI: advances in the fight against cancer
From combining treatments in unprecedented ways to deploying artificial intelligence for personalised medicine, a raft of new advances in the fight against cancer have been presented at the European Society for Medical Oncology (ESMO), which ends on Tuesday.
Here are some of the big announcements made at the five-day conference held in the Spanish city of Barcelona, which brought together 30,000 specialist doctors and researchers from around the world.
- Breastfeeding after cancer -
Women who breastfeed after receiving treatment for breast cancer do not have a higher risk of their cancer returning or of getting new tumours, according to two international studies presented at the conference.
This was also true for women carrying a genetic mutation called BRCA, which significantly increases the chance of developing breast cancer, the research found.
There had previously been concerns about pregnancy and breastfeeding after women had been diagnosed with breast cancer, because both can affect hormone levels.
"These results are key for women who wish to become pregnant and breastfeed their baby after breast cancer," said Fedro Alessandro Peccatori, a researcher and doctor at the European Institute of Oncology in Milan.
- New combination for lung cancer -
Immunotherapy, which stimulates the body's immune system to fight tumours, has already been shown to be an effective weapon against lung cancer.
On Saturday, the results of a phase two trial revealed promising signs against metastatic non-small cell lung cancer, which is when the most common form of lung cancer spreads to other parts of the body.
The trial tested a new combination of two different immunotherapies along with chemotherapy.
"By aiming at a second target of the immune system and combining these treatments, it seems that we are improving response rates -- that is, the number of patients who have their tumours shrink," Nicolas Girard, an oncologist at France's Curie Institute, told AFP.
- Rare pregnancy-linked cancer -
Another combination of immunotherapy and chemotherapy produced excellent results against a very rare form of pregnancy-related cancer which develops in the placenta. The cancer only occurs in around one out of every 10,000 pregnancies.
The combination of treatments led to 96 percent of the cancer in patients being eradicated.
"This is an exceptional result," said Benoit You, a France-based oncologist who presented the research.
- AI for personalised medicine? -
A huge artificial intelligence (AI) algorithm trained on a database of more than a billion images of tumours from around 30,000 patients in the United States also showed promise for future cancer treatment, researchers said Monday.
The model is capable of "detecting a certain number of molecular anomalies and mutations that the human eye is not always able to see," Fabrice Andre, research head at France's Gustave Roussy cancer centre, told AFP.
In the long term, the doctors hope this kind of AI will be able to help them offer personalised treatments for each patient.
- Hope for saving affected organs -
One of the main messages to come out of the ESMO conference was that combining immunotherapy with radiation therapy before surgery improves the overall survival rates for a growing number of cancers, including for the breast, bladder and cervix.
But receiving these kinds of treatments ahead of surgery seems to also allow for the affected organs themselves to be saved, Andre said.
"Organ preservation is absolutely essential to have a quality of life that is as close as possible to normal," he said.
Research presented on Monday showed encouraging results for preserving rectums in patients with cancer affecting this important part of the digestive tract. This only occurs after the treatments have caused the tumour to completely vanish.
"Until now the standard was surgery, but it seems we are entering a new era where surgery could be avoided," said David Sebag- Montefiore, an oncologist and researcher at the UK's University of Leeds.
There are hopes that this treatment combination could also have the potential to work for other cancers, such as those of the ear, nose and throat -- or lungs.
M.A.Colin--AMWN